Sanguine Biosciences Email Format
Biotechnology ResearchMassachusetts, United States51-200 Employees
Sanguine Biosciences is a biotechnology research company based in Woburn, Massachusetts, with 51-200 employees. It accelerates personalized medicine by enabling patients to access and contribute healthcare data and by facilitating participation in biomedical research through direct-to-patient engagement, in-home collection of fully annotated biospecimens, apheresis product offerings, and biorepository services. The company has supported translational, clinical, and cell and gene therapy research at 35 of the top 40 global pharmaceutical and biotechnology companies, aiming to shorten timelines and refine biomarkers in human trials. Sanguine has received multiple recognitions, including four consecutive Great Places to Work designations and placement on the Inc. 5000 list in 2022 (#2038), along with recognition on FORTUNE’s Best Small Workplaces and Best Workplaces in Biopharma. It has expanded operations and offerings, such as opening an apheresis donor center in Los Angeles in 2023 and launching LeukoCert GMP leukopaks in 2024 and synovial fluid and skin punch biopsy collections in 2025, with reported revenue in the $50–100 million range.
1-888-653-2347 
support@leadiq.com 
